ALK Gene Rearrangement
4 clinical trials · Condition
◉ Watch ALK Gene Rearrangement
| Record | Firm | Date |
|---|---|---|
| Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer (NCT04013542) | M.D. Anderson Cancer Center | 2019-09-13 |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT03707938) | M.D. Anderson Cancer Center | 2018-12-18 |
| Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) (NCT02201992) | ECOG-ACRIN Cancer Research Group | 2015-03-23 |
Track ALK Gene Rearrangement automatically
Every clearance here is in the API, with alerts when new ones post.